<DOC>
	<DOCNO>NCT00677404</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety autologous transplantation mononuclear cell without G-CSF patient chronic low limb ischemia .</brief_summary>
	<brief_title>Autologous Transplantation Bone Marrow Mononuclear Cell ( BM-MNC ) With Without Granulocyte-Colony Stimulation Factor ( G-CSF ) Treatment Chronic Lower Limb Ischemic Patients</brief_title>
	<detailed_description>Critical limb ischemia ( CLI ) result severe occlusive disease impairs distal limb perfusion point oxygen delivery longer adequate meet metabolic need tissue , even rest condition . The limit peripheral artery disease ( PAD ) compensatory mechanism , distal vasodilatation collateral formation , exceed point . PAD widespread disease , affect 15 % adult old 55 year . Formation true new blood vessel , angiogenesis , development collateral vessel preexist blood vessel , arteriogenesis , important pathophysiology vascular disease . By stimulate process might able provide alternative treatment strategy patient low limb ischemia . In response tissue injury remodeling , neovascularization usually occur via proliferation migration progenitor endothelial cell ( EPC ) preexist vasculature . The EPCs resident within bone marrow peripheral blood , seem implantation BM cell contribute injury-induced pathology induce neovascularization . Indeed , recent study show bone-marrow mononuclear cell ( BM-MNC ) implantation increase collateral vessel formation ischemic limb model patient limb ischemia . In addition , granulocyte-colony stimulation factor could mobilize EPCs peripheral blood . After BM-MNC implantation , G-CSF contribute EPC PB effective angiogenesis PAD patient . In study , Bone marrow puncture perform common manner . The iliac crest puncture epidural anesthesia 400 mL bone marrow aspirate . The MNCs isolate good manufacturing practice condition Ficoll density separation intramuscularly inject ( 40 site , 3 × 3 cm distance , 1-1.5 cm deep , ischemic leg . In patient G-CSF ( 10 microgr/day ) administration subcutaneous injection day cell injection 5 day .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Presence Critical Limb ischemia accord guideline Transatlantic Consensus Group ( TASC ) Rutherford grade II III . Perfusion measure absolute perfusion pressure anklebrachial index ( ABI ) transcutaneous oxygen tension ( TcpO2 ) ; inclusion , ABI le equal 0.6 absolute ankle pressure must less 60 mmHg . If ABI technically feasible , e.g . patient medium calcification , inclusion criterion tcpO2 value ( supine , forefoot , 44°C ) less 20 mmHg tissue loss , tcpO2 less 40 mmHg tissue loss . No sufficient response best standard care deliver six week . No surgical radiological interventional option revascularisation confirm vascular surgeon interventional radiologist Signed informed consent Absence lifethreatening complication ischemic limb Expected life span less six month Bone marrow disease preclude transplantation ( eg lymphoma , leukaemia , myelodysplastic syndrome others ) Patients poorly control diabetes mellitus ( HbA1C &gt; 8 % ) Patients renal insufficiency ( creatinine &gt; 2.5 ) . Patients evidence infectious disease determine e. medical finding . Pregnant woman ( woman capable childbearing must negative pregnancy test ) . Patients cognitive impairment . Other comorbid disease would expect result less one year life expectancy Past malignancy history chemotherapy radiation affect bone marrow . History inflammatory progressively fibrotic condition : .e.g. , rheumatoid arthritis , systemic lupus erythematosis , vasculitic disorder , idiopathic pulmonary fibrosis , retroperitoneal fibrosis Infection evidence WBC count &gt; 15,000 and/or temperature 38C . Large area cellulitis afflict limb opinion ofthe investigator would require institution antibiotic OR evidence osteomyelitis corroborate radiographic scintigraphic examination Cardiovascular condition : EF &lt; 30 % Acute ST elevation myocardial infarction ( MI ) within 1month ; Transient ischemic attack stroke within 1 month ; Severe valvular disease CVA Patients history organ transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Peripheral vascular disease</keyword>
	<keyword>chronic low limb ischemia</keyword>
</DOC>